METTL16 Inhibits Lens Epithelial Cells Function in Diabetic Cataract via m 6 A-Modified DKK1-Mediated Wnt/β-Catenin Signaling
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.1.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2026. Verfasst von Bei Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Eye Hospital and School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Intercellular Signaling Peptides and Proteins, Cataract, Wnt Signaling Pathway, Epithelial Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Eye Hospital and School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.
- National Clinical Research Center for Ocular Diseases, State Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
Zitieren
APA
Zhang, B., Sun, Y., Jiang, X., Hu, Z., Wang, X., & Zhao, Y. E. (2026). METTL16 Inhibits Lens Epithelial Cells Function in Diabetic Cataract via m 6 A-Modified DKK1-Mediated Wnt/β-Catenin Signaling. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.1.1
Vancouver
Zhang B, Sun Y, Jiang X, Hu Z, Wang X, Zhao YE. METTL16 Inhibits Lens Epithelial Cells Function in Diabetic Cataract via m 6 A-Modified DKK1-Mediated Wnt/β-Catenin Signaling. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.1.1
BibTeX
@article{Zhang2026,
author = {Zhang, Bei and Sun, Yahui and Jiang, Xiaohui and Hu, Zhixuan and Wang, Xue and Zhao, Yun-E},
title = {METTL16 Inhibits Lens Epithelial Cells Function in Diabetic Cataract via m 6 A-Modified DKK1-Mediated Wnt/β-Catenin Signaling},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.1.1}
}
EUVIMED